Consequently, a new disease- and molecular-specific score, the Lung-molGPA, has been evaluated for its predictive value for overall survival in NSCLC patients by updating the original disease-specific GPA with the EGFR and ALK status [7]. Here, ALK is linked to non-small cell lung carcinoma.